1-4 of 4
Authors: Francesco Franchi
Sort by
Journal Article
Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysis
Mattia Galli and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 6, September 2024, Pages 526–536, https://doi.org/10.1093/ehjcvp/pvae036
Published: 16 May 2024
Journal Article
Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy
Mattia Galli and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 7, November 2022, Pages 728–737, https://doi.org/10.1093/ehjcvp/pvac022
Published: 30 March 2022
Journal Article
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
Luis Ortega-Paz and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 7, November 2022, Pages 677–686, https://doi.org/10.1093/ehjcvp/pvab070
Published: 14 September 2021
Journal Article
Impact of chronic kidney disease on the pharmacodynamic and pharmacokinetic effects of ticagrelor in patients with diabetes mellitus and coronary artery disease
Francesco Franchi and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 5, September 2022, Pages 452–461, https://doi.org/10.1093/ehjcvp/pvab042
Published: 11 June 2021
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals